Today's investment: DA an gene HTC series reviews

(2009-5-11 to 2009-5-15) this week a-share market high volatility, the Shanghai Composite Index to create 2,670 points of the current round of new highs. Shanghai and Shenzhen 300 closed at 2796.12, a week + 0.25%. A slight contraction, the daily turnover in Shanghai market was reduced from 159.2 billion in the previous week to 134 billion yuan, the Shenzhen market from 83.1 billion to 70.9 billion yuan.　　In this week's strong stock, we chose the Tamiflu gene (002030) with the HTC Warp (002144) to give a brief comment. Source: Today's investment Notes: 1 Basic diagnostics: Scoring interval 1-100 points, the higher the score indicates that based on the growth rate, profitability and other aspects of the fundamentals of the more prominent; technical surface diagnosis: Scoring interval of 1-100 points, higher scores pure technical analysis of indicators the better　　Institutional identity: A score of 1-100 points, the higher the score indicates that analysts and funds and other institutions of the higher degree of recognition. 2) Today's investment stock diagnosis is based on the listed company fundamentals, stock technology, institutional identity "triple comparative advantage" of the data model, combined with other important financial indicators and the summary of more than 1800 analyst research results as the revised indicators, the final form of today's unique rational stock diagnosis system.　　Comprehensive diagnosis to star-level, divided into one star, two stars, Samsung, four-star, five-star five standards, the higher stars, said that the only stock of the intrinsic value of the better, the ability to resist risk, on the contrary, the ability to resist risk, investment should pay attention to investment risk.　　3 Information provider: Invest in financial information company today. Da an gene (002030) May 11, The Da ' an gene published a swine flu virus detection kit in Hong Kong to verify the success of the Bulletin. This week caused a huge influx of money, detonated the stock five days a huge number of closures, a week soared 60.97%, turnover rate of up to 59.41%. At present, two cases of swine flu have been diagnosed in China. The successful development of this product is likely to be procured by the health department and the Immigration Inspection Agency. GF Securities analysts believe that the company only theoretically successful in this product, but the use of the product prospects are still greater uncertainty, prices, sales volume can not be expected, so the company will not make changes to earnings forecasts, still think the company 09-11 years EPS for 0.28 yuan, 0.38 yuan, 0.50 yuan, Maintain a "buy" investment rating based on a bullish outlook for the long-term development of the company.　　In addition, the company's new reagent products have not passed the state Food and Drug Administration of the verification, assessment and approval of registration, so the wide application in the clinical field there is a lot of uncertainty. HTC Warp Knitting (002144) This week bucked the trend up 33.33%, the turnover rate is as high as 77.27%. The company is mainly engaged in warp knitted fabric weaving, dyeing and finishing and sales. About 90% of the company's revenue comes from fabric and trade every year. East China Sea Securities in the latest research report that, as the auto sales market, the company's car interior orders in the new year after the growth of the obvious. At the same time due to upstream rawPrice rebound, the company's elastic fabric prices are expected to increase by an average of about 3000 yuan per ton. Currently under construction of Automotive Interior Inspection Center will help enhance the company's automotive interior business competitiveness. In the second half of the year the company's traditional textile business performance growth will rebound. Meanwhile, the company plans to acquire 100% stake in Shenzhen's Wilder medical electronics through Non-public offerings. The company's main products handheld and Portable B Super market share. They believe that diversification of the company will help to reduce the single operating traditional textile industry performance fluctuation risk, to bring new profit growth. After the company and the subscribers promised to complete the transaction, the net profit of the original business in 2009-2011 was not less than 20% per annum, and Wilder's net profit growth rate was not less than 15%. Conservatively estimated the 09/10-year net profit of 23.8 million yuan/27.37 million yuan (at least 15% growth rate according to the commitment), the HTC textile business 09/10 years attributable to the parent company's net profit of 867.5/11.104 million yuan.　　09/10 years of textile and medical equipment business diluted earnings per share 0.215/0.255 yuan, to give a "neutral" rating. (Invest today-Li Chong)